Here, we found that NF-κB knockdown led to a decreased inflammatory spread and invasion capacity in both CRC cell lines HCT116 and RKO, whereby resveratrol treatment of NF-κB down-regulated CRC cells significantly enhanced their ability to act in a synergistic, powerful anti-inflammatory way. Here, NFKB1 is linked to colorectal carcinoma.